Patents by Inventor James W. McFarland

James W. McFarland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5545624
    Abstract: The present invention relates to derivatives of 16-membered ring macrolide antibiotics rosaramicin, repromicin, 5-mycaminosyltylonide, desmycosin, lactenocin, O-demethyllactenocin, cirramycin A1, and 23-deoxymycaminosyltylonide, which are useful against bacterial and mycoplasmic pathogens in animals. Also claimed are a pharmaceutical composition of such derivatives and their use in treating bacterial and mycoplasmic infections in animals.
    Type: Grant
    Filed: January 11, 1995
    Date of Patent: August 13, 1996
    Assignee: Pfizer Inc.
    Inventors: Scott J. Hecker, Martin R. Jefson, James W. McFarland
  • Patent number: 5506235
    Abstract: This invention relates to compounds of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are as defined hereinbelow that exhibit activity as immunostimulants.
    Type: Grant
    Filed: January 2, 1994
    Date of Patent: April 9, 1996
    Assignee: Pfizer Inc.
    Inventors: Mikel P. Moyer, James W. McFarland
  • Patent number: 4797486
    Abstract: Certain trans-3-[3-(3-hydroxy-2-piperidyl)-2-oxopropyl]thieno[3,2-d]pyrimidin-4(3H )-one and furo[3,2-d]pyrimidin-4(3H)-one derivatives, a method of using same as anticoccidial agents, intermediates therefor, and a process for certain intermediates therefor.
    Type: Grant
    Filed: October 14, 1987
    Date of Patent: January 10, 1989
    Assignee: Pfizer Inc.
    Inventors: Edward A. Glazer, James W. McFarland
  • Patent number: 4725599
    Abstract: Certain trans-3-[3-(3-hydroxy-2-piperidyl)-2-oxopropyl]thieno[3,2-d]pyrimidin-4(3H )-one and furo[3,2-d]pyrimidin-4(3H)-one derivatives, a method of using same as anticoccidial agents, intermediates therefor, and a process for certain intermediates therefor.
    Type: Grant
    Filed: September 8, 1986
    Date of Patent: February 16, 1988
    Assignee: Pfizer Inc.
    Inventors: Edward A. Glazer, James W. McFarland
  • Patent number: 4009160
    Abstract: 6-(Aminomethyl substituted phenyl- and thienylacetamido)penicillanic acid and esters, and synthetic methods for the preparation thereof.
    Type: Grant
    Filed: February 17, 1976
    Date of Patent: February 22, 1977
    Assignee: Pfizer Inc.
    Inventors: James W. McFarland, Colin Thomson
  • Patent number: 4002636
    Abstract: A process for inhibiting plant growth comprising contacting a plant or its growth area with an effective amount of certain para-halophenyl substituted triazolines. A series of certain novel substituted tetrahydro-oxothiazolo-triazolium compounds useful as herbicides. A novel process for preparing 3-phenyl-4-oxo-1,2,3-triazoline by contacting benzenediazoniumchloride and an .alpha.-amino carboxylic acid and cyclodehydrating the triazene produced using acetic anhydride and pyridine.
    Type: Grant
    Filed: December 13, 1974
    Date of Patent: January 11, 1977
    Assignee: Pfizer Inc.
    Inventors: Marwan J. Abu-El-Haj, James W. McFarland
  • Patent number: 3997527
    Abstract: 6-(Aminomethyl substituted phenyl- and thienylacetamido)-penicillanic acid and esters, and synthetic methods for the preparation thereof.
    Type: Grant
    Filed: February 17, 1976
    Date of Patent: December 14, 1976
    Assignee: Pfizer Inc.
    Inventors: James W. McFarland, Colin Thomson
  • Patent number: 3966710
    Abstract: 6-(Aminomethyl substituted phenyl- and thienylacetamido)-penicillanic acid and esters, and synthetic methods for the preparation thereof.
    Type: Grant
    Filed: November 12, 1974
    Date of Patent: June 29, 1976
    Assignee: Pfizer Inc.
    Inventors: James W. McFarland, Colin Thomson
  • Patent number: 3948911
    Abstract: Compounds of the formula ##SPC1##Wherein X is a 6- or 7-position substituent selected from the group consisting of formyl, acetyl, hydroxymethyl, 1-hydroxyethyl and ##EQU1## wherein Y is selected from the group consisting of hydrogen and methyl; R.sub.1 is hydrogen or methyl; R.sub.2, when taken separately, is hydrogen or alkyl having 1 to 4 carbon atoms; R.sub.3, when taken separately, is hydrogen, alkyl having 1 to 4 carbon atoms, --(CH.sub.2).sub.n OH, --(CH.sub.2).sub.n OCH.sub.3, --(CH.sub.2).sub.n NH.sub.2, ##EQU2## or ##EQU3## wherein n is 2 or 3 and R.sub.2 and R.sub.3, when taken together with the nitrogen atom to which they are attached, form a member selected from the group consisting of pyrrolo, pyrrolidino, piperidino, morpholino, thiomorpholino, piperazino, N-(lower alkyl)piperazino, N-hydroxy(lower alkyl)piperazino, N-(lower alkanoyl)piperazino and N-carbo(lower alkoxy)piperazino and the pharmaceutically acceptable acid addition salts of those compounds wherein R.sub.2 has an .omega.
    Type: Grant
    Filed: November 19, 1974
    Date of Patent: April 6, 1976
    Assignee: Pfizer Inc.
    Inventor: James W. McFarland
  • Patent number: 3939174
    Abstract: A process for inhibiting plant growth comprising contacting a plant or its growth area with an effective amount of certain para-halophenyl substituted triazolines. A series of novel mesoionic para-halophenyl substituted triazolines. A novel process for preparing 3-phenyl-4-oxo-1,2,3-triazoline by contacting benzenediazoniumchloride and an .alpha.-amino carboxylic acid and cyclodehydrating the triazene produced using acetic anhydride and pyridine.
    Type: Grant
    Filed: December 13, 1974
    Date of Patent: February 17, 1976
    Assignee: Pfizer Inc.
    Inventors: Marwan J. Abu-El-Haj, James W. McFarland
  • Patent number: 3933843
    Abstract: A process for inhibiting plant growth comprising contacting a plant or its growth area with an effective amount of certain para-halophenyl substituted triazolines. A series of novel mesoionic para-halophenyl substituted triazolines. A novel process for preparing 3-phenyl-4-oxo-1,2,3-triazoline by contacting benzenediazoniumchloride and an .alpha.-amino carboxylic acid and cyclodehydrating the triazene produced using acetic anhydride and pyridine.
    Type: Grant
    Filed: December 13, 1974
    Date of Patent: January 20, 1976
    Assignee: Pfizer Inc.
    Inventors: Marwan J. Abu-El-Haj, James W. McFarland
  • Patent number: 3931174
    Abstract: Novel quinoxaline-1,4-dioxides of the formula ##SPC1##Wherein R is hydrogen or methyl;Y is lower alkyl; andn is 0, 1, or 2;Methods for their preparation; and their use as antibacterial agents and agents for promoting growth and improving feed efficiency of animals. Additionally, those compounds wherein n is 0 or 1 serve as intermediates for preparation of compounds wherein n is 1 or 2.
    Type: Grant
    Filed: January 23, 1974
    Date of Patent: January 6, 1976
    Assignee: Pfizer Inc.
    Inventor: James W. McFarland